Back to all blogs

Life Sciences is ready for agentic transformation -- but only if the foundation is right

Most AI initiatives in life sciences fail because they bolt intelligence onto broken processes and disconnected data.

Most AI initiatives in life sciences fail because they bolt intelligence onto broken processes and disconnected data.

The Alphient approach is different. With Prime (pro-code) and Prime (low-code), we start with three pillars:

Structured Knowledge

  • Pipeline dashboards, competitive intelligence & therapeutic-area maps
  • Molecular Intelligence Graph
  • Pipeline Valuation Hub

Automated Process Packs

  • Portfolio review cycles with stage-gate governance automation
  • Portfolio Review Pipeline

Intelligent AI Agents

  • Biomarker Discovery Agent
  • Portfolio Scoring Agent
  • Competitive Intel Agent

The business questions this unlocks:

  • R&D Pipeline Health
  • Cost of Development
  • Researcher Productivity
  • Trial Speed
  • AI in R&D

AI agents for R&D pipeline, cost per molecule, researcher productivity, and regulatory.

Knowledge. Process. Agents. That is the transformation formula.

Open full visual Talk to us